Efficiency of HPV 16 L1/E7 DNA immunization: Influence of cellular localization and capsid assembly
- 5 April 2006
- Vol. 24 (15) , 2952-2965
- https://doi.org/10.1016/j.vaccine.2005.12.023
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe
This publication has 52 references indexed in Scilit:
- Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy womenVaccine, 2004
- Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary courseJournal of Medical Virology, 2003
- Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in miceGene Therapy, 2003
- Human Papillomavirus Type 16 L1 Capsomeres Induce L1-Specific Cytotoxic T Lymphocytes and Tumor Regression in C57BL/6 MiceJournal of Virology, 2003
- Enhancement of Capsid Gene Expression: Preparing the Human Papillomavirus Type 16 Major Structural Gene L1 for DNA Vaccination PurposesJournal of Virology, 2001
- HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans afterin vitro vaccinationInternational Journal of Cancer, 2001
- DNA VACCINESAnnual Review of Immunology, 1997
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.Journal of Clinical Pathology, 1990
- Human papillomavirus type 16 DNA sequenceVirology, 1985